Anti-Human CXCL13/BCA-1/BLC Reference Antibody (TJX7)

Description: Anti-Human CXCL13/BCA-1/BLC (TJX7) (BS11261) is a research-grade recombinant antibody targeting SCYB13. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Human
Isotype: IgG
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: SCYB13,BLC,CXCL13,Bcell-attractingchemokine1,Blymphocytechemoattractant,Small-induciblecytokineB13,CXCchemokineBLC,Angie,C-X-Cmotifchemokine13,BCA-1,BCA1
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: TJX7
Background: C-X-C motif chemokine 13 (CXCL13/BCA-1) is a ~12 kDa protein. Chemotactic for B-lymphocytes but not for T-lymphocytes, monocytes and neutrophils. Does not induce calcium release in B-lymphocytes. Binds to BLR1/CXCR5.
Note: For research use only. Not suitable for clinical or therapeutic use.